American Financial Group Inc Gilead Sciences, Inc. Transaction History

American Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $3 Million - $3.42 Million	-50,000 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $3.62 Million - $4.2 Million	-50,000 Reduced 50.0%	50,000 $3.85 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $1.25 Million - $1.6 Million	-20,000 Reduced 16.67%	100,000 $7.48 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $8.65 Million - $10.3 Million	120,000	120,000 $9.72 Million

1,905

1.02B

12M

9.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on American Financial Group Inc with notifications on news.